Best Peptide for Anti-Inflammatory Research
GHK-Cu is the premier peptide for anti-inflammatory research, downregulating TNF-α, IL-6, and IL-1β at the transcriptional level. Its nanomolar potency and broad gene-modulation profile make it the most efficient tool for macrophage and cytokine signaling studies.
TOP RECOMMENDATION
GHK-Cu — Glycyl-Histidyl-Lysine-Copper Complex
GHK-Cu is the established leader for anti-inflammatory and cytokine modulation research. Its ability to downregulate TNF-α, IL-6, and IL-1β while simultaneously upregulating IL-10 creates a comprehensive resolution profile unmatched by linear peptides. The copper center modulates NF-κB pathway activation, and the tripeptide operates at nanomolar concentrations — making it the most cost-efficient anti-inflammatory research tool in the catalog. BPC-157 contributes anti-inflammatory effects through nitric oxide synthesis enhancement and localized vasodilation, which is relevant for tissue-specific inflammation models. However, for broad cytokine profiling, macrophage signaling, and high-throughput anti-inflammatory screening, GHK-Cu's transcriptional-level gene modulation and extraordinary potency per nanomole make it the definitive choice.
WHY IT WINS
- Downregulates pro-inflammatory cytokines TNF-α, IL-6, and IL-1β at the gene transcription level across approximately 4,000 modulated genes
- Effective at nanomolar concentrations (1–100 nM) in LPS-stimulated macrophage models, making it extraordinarily cost-efficient for screening
- Upregulates anti-inflammatory IL-10 in parallel with pro-inflammatory downregulation, creating a balanced cytokine resolution profile
- Copper-mediated redox modulation suppresses NF-κB pathway activation in inflammatory cell models
- Lower molecular weight enables rapid cellular uptake without specialized transfection or delivery systems
APPLICATION SUITABILITY MATRIX
| RESEARCH APPLICATION | GHK-Cu | BPC-157 |
|---|---|---|
| TNF-α Downregulation | ||
| IL-6 Suppression | ||
| IL-10 Upregulation | ||
| NF-κB Pathway Modulation | ||
| NO-Mediated Vasodilation | ||
| Macrophage Polarization | ||
| Cost per Screening Plate | ||
| Neutrophil Chemotaxis |
IDEAL RESEARCH APPLICATIONS
- LPS-stimulated macrophage cytokine profiling (TNF-α, IL-6, IL-1β, IL-10)
- Chronic inflammatory cell culture models
- NF-κB pathway activation and suppression assays
- Neutrophil chemotaxis and respiratory burst studies
- High-throughput anti-inflammatory compound screening
ALTERNATIVE: BPC-157
RUNNER-UP
BPC-157 — Body Protection Compound-157
Consider when:
- Direct nitric oxide synthesis enhancement provides an alternative anti-inflammatory mechanism through vasodilation and blood flow modulation
- Superior reconstituted stability (30 days vs 7 days) for longitudinal inflammatory monitoring studies
- Consider for localized tissue inflammation models where GHK-Cu's systemic gene modulation is less relevant than BPC-157's localized NO signaling
ANALYTICAL SPECIFICATIONS
Compound
Glycyl-Histidyl-Lysine-Copper Complex
CAS Number
89030-95-5
Purity (HPLC)
≥ 99.0%
Molecular Weight
403.9 g/mol
Sequence
Gly-His-Lys (GHK) complexed with Cu²⁺
Verification
HPLC + MS per batch
FREQUENTLY ASKED QUESTIONS
Why is GHK-Cu better than BPC-157 for anti-inflammatory research?
GHK-Cu downregulates TNF-α, IL-6, and IL-1β at the transcriptional level across thousands of genes, while upregulating IL-10. BPC-157 reduces inflammation primarily through localized nitric oxide synthesis and vasodilation. For broad cytokine profiling and gene-level studies, GHK-Cu offers a more comprehensive and potent mechanism.
What is the optimal GHK-Cu concentration for LPS-stimulated macrophages?
For RAW 264.7 or primary macrophage LPS stimulation models, GHK-Cu is typically evaluated at 1–100 nM (0.4–40 mcg/ml) added 1 hour before LPS challenge. Cytokine readouts (TNF-α, IL-6, IL-10) are collected at 6–24 hours post-stimulation by ELISA or qPCR.
Does GHK-Cu modulate the NF-κB pathway?
Yes. Research indicates GHK-Cu suppresses NF-κB activation in inflammatory cell models, which is the master regulator of pro-inflammatory cytokine transcription. This NF-κB suppression is copper-dependent and correlates with the observed TNF-α and IL-6 downregulation.
Can I study GHK-Cu in neutrophil respiratory burst assays?
Yes. GHK-Cu has been evaluated in neutrophil chemotaxis and respiratory burst models. Its copper center participates in redox chemistry that modulates reactive oxygen species generation. Typical concentrations range from 10–100 nM.
How does GHK-Cu compare to dexamethasone in anti-inflammatory assays?
GHK-Cu and dexamethasone operate through different mechanisms. Dexamethasone is a glucocorticoid receptor agonist with broad immunosuppressive effects and significant side-effect profiles. GHK-Cu modulates cytokine gene expression more selectively, without glucocorticoid receptor activation. Many researchers use both as comparative controls.
REFERENCES
- [1]Pickart, L. & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide. International Journal of Molecular Sciences, 19(7), 1987.
- [2]Pickart, L. et al. (2015). GHK peptide as a natural modulator of multiple cellular pathways. Skin Pharmacology and Physiology, 28(3), 147–158.
- [3]Siméon, A. et al. (2000). Copper-GHK increases extracellular matrix synthesis. Life Sciences, 67(18), 2257–2265.
TOP RECOMMENDATION
GHK-Cu
Glycyl-Histidyl-Lysine-Copper Complex
QUICK LINKS
RELATED RESEARCH GOALS
RESEARCH USE ONLY. All compounds are strictly for in-vitro laboratory research by qualified professionals. Not for human consumption, veterinary use, or clinical application.